ClinicalTrials.govpublic full text
Dose-escalating AZD1775 + Concurrent Radiation + Cisplatin for Intermediate/High Risk HNSCC
carcinoma, squamous cell of head and neck, azd1775, cisplatin, head and neck squamous cell carcinoma, hnscc, chemoradiotherapy, radiotherapy, crt, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 918192
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.